answersLogoWhite

0

Something that acts to stop bleeding (hemo=blood statis=stop).

User Avatar

Wiki User

16y ago

What else can I help you with?

Related Questions

What are the medicinal actions of Grains-of-paradise fruit?

An effective anti-fungal and antimicrobial agent, purgative, galactogogue, anthelmintic, hemostatic agent.


What are the medicinal actions of gardenia?

Calming irritability, anti-inflammatory, hemostatic agent, anti-viral, astringent, expectorant, antiseptic, analgesic.


You're required to treat the victim of an IED explosion As you prepare to apply an Emergency Bandage, you?

always apply a hemostatic agent before the bandage


What is hemostatic?

The word hemostatic means that blood has stopped. Usually it is used when blood is stopped from going to a damaged blood vessel.


Are hemostatic bladder infections dangerous?

Yes


You're required to treat the victim of an IED explosion As you prepare to apply an Emergency Bandage you?

A hemostatic agent should be applied before the bandage. (The wound should be sealed only with a nonporous material.)


You're required to treat the victim of an IED explosion As you prepare to apply an Emergency Bandage what should you do you?

A hemostatic agent should be applied before the bandage. (The wound should be sealed only with a nonporous material.)


What is the medical term meaning a drug that reduces bleeding?

The medical term for a drug that reduces bleeding is "hemostatic agent." These drugs work by promoting blood clotting and stopping the flow of blood.


What is the third response of the coagulation process?

hemostatic plug formation


Importance of oxalic acid in medicine?

It is used as hemostatic in vetirenary medicine


What is ugurol?

It is an antifibrinolytic hemostatic used to control severe hemorrhaging. The generic name is tranexamic acid.


Hemostatic Agents Market?

The Hemostatic Agents Market in the Asia Pacific is expected to grow at a relatively higher CAGR. Baxter (the leading organization in the global market), plans to expand its operation in emerging nations such as India and China to enhance its accessibility. This is expected to propel the growth rate of the Asia Pacific hemostatic agents market. Meanwhile, the Europe market is likely to expand at a low CAGR due to the presence of a smaller patient pool compared to the Asia Pacific and North America.